Efficacy of Pembrolizumab and Olaparib Combination Observed in a Subset of Patients with HRD Metastatic Pancreatic Cancer By Ogkologos - April 7, 2026 5 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the POLAR study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Asciminib NHS England Lung Cancer Screening Programme Demonstrates that it is Feasible and Scalable for Reaching High-Risk and Underserved Populations ESMO Welcomes European Parliament (EP) Draft Report on Psychosocial Risks at Work (PSR) as a Critical Opportunity to Protect the Wellbeing of the Cancer... MOST POPULAR An Oncology Hospital at Home Model of Acute Care Shows Promise May 21, 2021 Combination Therapy with Venetoclax Approved for Chronic Lymphocytic Leukemia June 17, 2019 Studies Show Immunotherapy Improves Long-Term Survival in Growing Number of Cancers September 14, 2024 Women and girls in science: We won’t stop pushing for progress February 11, 2023 Load more HOT NEWS When Natural Disasters Strike, This Program Helps Provide Relief To People... A new target to slow down ageing and reduce blood cancer... Women Over Age 65 Years with Pathogenic Variants in Cancer Predisposition... Nurse Diagnosed with Stage IV Cancer After Thinking Her Pain Was...
